The longevity industry is now worth over $100 billion per year. From DNA methylation clocks to multi-cancer blood tests and GLP-1 medications, the promises are bold.But what actually predicts lifespan?In this episode, Dr. Jordan Feigenbaum and Dr. Austin Baraki break down the science behind biological clocks, the real story on GLP-1–related muscle loss, and introduce the Barbell Medicine “Vital Five” — a clinically grounded framework for health and longevity.Key Points:The Three Generations of Biological Clocks: Understanding the evolution of DNA methylation tests from sim...
The longevity industry is now worth over $100 billion per year. From DNA methylation clocks to multi-cancer blood tests and GLP-1 medications, the promises are bold.
But what actually predicts lifespan?
In this episode, Dr. Jordan Feigenbaum and Dr. Austin Baraki break down the science behind biological clocks, the real story on GLP-1–related muscle loss, and introduce the Barbell Medicine “Vital Five” — a clinically grounded framework for health and longevity.
Key Points:
- The Three Generations of Biological Clocks: Understanding the evolution of DNA methylation tests from simple chronological markers (Horvath) to sophisticated predictors of mortality (GrimAge) and functional decline (DunedinPACE).
- Descriptive vs. Prescriptive Metrics: Why a biological age score acts as a lagging indicator rather than a tool for clinical decision-making, compared to traditional risk factors like blood pressure and ApoB.
- GLP-1s and Sarcopenia Reality: A nuanced look at lean mass loss during semaglutide and tirzepatide treatment, emphasizing the difference between total lean mass and actual skeletal muscle quality.
- Weight-Independent Benefits of Incretins: Analyzing data from the SELECT and FLOW trials regarding the direct cardioprotective and renal benefits of GLP-1 receptor agonists.
- The Limitations of Early Detection: Why multi-cancer early detection (MCED) tests can lead to diagnostic loops and how clinical utility differs from marketing promises.
- The Barbell Medicine Vital Five: A definitive framework for longevity focusing on blood pressure, ApoB, VO2 max, relative strength, and body composition.
- Neurodegenerative Research Outlook: A critical review of the EVOKE trials and the potential (or lack thereof) for current weight-loss medications in treating established Alzheimer's disease.
Next Steps
- For evidence-based resistance training programs: barbellmedicine.com/training-programs
- For individualized training consultation: barbellmedicine.com/coaching
- Explore our full library of articles on health and performance: barbellmedicine.com/resources
- To join Barbell Medicine Plus and get ad-free listening, product discounts, exclusive content, and more: https://barbellmedicine.supercast.com/
- To consult with Drs. Baraki or Feigenbaum email us at support@barbellmedicine.com
Timestamps:
- 00:00 – The $100 Billion Longevity Industry
- The explosion of biological age testing, cancer screening startups, and anti-aging marketing.
- 01:45 – The “Eyeball Test”: Physician Intuition vs Biological Age Scores
- Does looking “older” or “younger” actually mean anything clinically?
- Biological Clocks
- 04:33 – What Is DNA Methylation? Epigenetic “Post-It Notes”
- How biological clocks are built.
- 07:28 – The Three Generations of Biological Clocks
- Horvath → GrimAge → DunedinPACE.
- 12:01 – Why Biological Age Is a Lagging Indicator
- Why blood pressure and ApoB still explain most of the variance.
- 16:30 – Should You Buy a Biological Age Test?
- Clinical utility vs curiosity.
- Multi-Cancer Early Detection Tests
- 17:10 – The Promise of Multi-Cancer Early Detection Tests
- The appeal of a single blood draw.
- 23:20 – The Pathfinder Study: Sensitivity, Specificity, and False Positives
- Why early-stage detection remains limited.
- 28:30 – Lead-Time Bias and Overdiagnosis
- Finding cancer earlier vs actually improving survival.
- 29:30 – Who (If Anyone) Should Consider MCED Testing?
- 31:00 – Why Exercise Guidelines May Be Incomplete
- From “just move” to measurable targets.
- 38:00 – VO2 Max: The Strongest Predictor of Survival?
- Elite cardiorespiratory fitness and mortality risk.
- 40:20 – Strength vs Power: Which Matters More?
- Why muscular power may be underestimated.
- 43:45 – Comparing VO2 Max and Power Risk Reductions
- What the hazard ratios actually suggest.
- 44:40 – Elite VO2 Max Targets by Age and Sex
- Practical benchmarks.
- 45:30 – Strength Targets: Leg Press, Chest Press, Grip Strength
- What the limited data suggests.
- 49:00 – Power Benchmarks: Vertical Jump and Aging
- 50:10 – Why Progress Matters More Than Just “Doing Exercise”
- Dose-response data on strength and VO2 improvements.
- 52:30 – The Barbell Medicine Longevity Exercise Prescription
- From minimum guidelines to optimal training volumes.
- 55:15 – Protein Restriction and mTOR: The Longevity Hypothesis
- Rodent data and mechanistic concerns.
- 59:50 – Human Outcome Data: Total vs Plant Protein
- What prospective studies actually show.
- 01:03:50 – Age-Dependent Protein Effects?
- Middle age vs older adults.
- 01:04:15 – Practical Protein Recommendations
- Where BBM currently stands.
- 01:08:04 – Are GLP-1s Just Weight Loss Drugs?
- Reframing incretin therapies
- 01:12:06 – The Muscle Loss Controversy
- Lean mass vs skeletal muscle vs function.
- 01:18:20 – STEP 1 and the 40% Lean Mass Claim
- Context and measurement limitations.
- 01:27:30 – Functional Outcomes: SEMA-LEAN Data
- Strength, sarcopenia risk, and muscle quality.
- 01:31:50 – Beyond Weight Loss: SELECT Trial Cardiovascular Data
- 20% reduction in major adverse cardiac events.
- 01:24:40 – FLOW Trial: Kidney Protection
- Renal outcomes in high-risk patients.
- 01:23:20 – Retatrutide and Multi-Receptor Incretins (TRIUMPH-4)
- 01:31:50 – Alzheimer’s Disease and the EVOKE Trials
- Managing expectations for neurodegenerative disease.
- 01:41:00 – HRT and the Women’s Health Initiative Reanalysis
- Age-stratified cardiovascular risk.
- 01:49:55 – Testosterone Deficiency in Men
- Obesity, TRT, and cardiovascular outcomes.
- The Barbell Medicine Vital Five
- 01:50:57 – Introducing the Vital Five Framework
- A practical longevity model.
- 01:56:00 – Blood Pressure: The Foundational Metric
- 01:58:00 – ApoB and Atherogenic Risk
- 01:59:45 – VO2 Max as a Clinical KPI
- 02:00:55 – Relative Strength and Function
- 02:02:30 – Body Roundness Index and Body Composition
References:
- Biological Clock
- https://pmc.ncbi.nlm.nih.gov/articles/PMC8853656/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC12038942/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC11424583/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC6366976/
- Cancer Screening
- https://ascopubs.org/doi/10.1200/JCO.2019.37.15_suppl.5574
- https://www.thelancet.com/article/S1470-2045(23)00277-2/fulltext
- https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)01700-2/fulltext
- https://www.nhs-galleri.org/
- Exercise
- https://bjsm.bmj.com/content/56/13/755
- https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2807854
- https://pubmed.ncbi.nlm.nih.gov/35442242/
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915309/?mc_cid=87bfcaaa3a&mc_eid=8786146256
- https://pmc.ncbi.nlm.nih.gov/articles/PMC9012529/
- https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2707428
- https://pubmed.ncbi.nlm.nih.gov/35228201/
- https://pubmed.ncbi.nlm.nih.gov/35662329/
- https://academic.oup.com/biomedgerontology/article/77/4/781/6354429
- https://www.sciencedirect.com/science/article/abs/pii/S0025619625001004
- https://pmc.ncbi.nlm.nih.gov/articles/PMC12131147/
- https://pubmed.ncbi.nlm.nih.gov/18595904/
- https://pubmed.ncbi.nlm.nih.gov/12242311/
- Protein
- https://pubmed.ncbi.nlm.nih.gov/40418846/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC7250948/
- https://pubmed.ncbi.nlm.nih.gov/39110456/
- https://pubmed.ncbi.nlm.nih.gov/24606898/
- https://www.bmj.com/content/370/bmj.m2412
- GLP-1
- https://www.cell.com/cell-metabolism/abstract/S1550-4131(26)00008-2
- https://www.nejm.org/doi/full/10.1056/NEJMoa2307563
- https://www.nejm.org/doi/abs/10.1056/NEJMoa2403347
- https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01296-0/fulltext
- https://link.springer.com/article/10.1007/s11154-025-09991-4
- https://pmc.ncbi.nlm.nih.gov/articles/PMC12338914/
- HRT
- https://pubmed.ncbi.nlm.nih.gov/25754617/
- https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(25)00211-6/abstract
- https://www.nejm.org/doi/full/10.1056/NEJMoa2215025
- https://pmc.ncbi.nlm.nih.gov/articles/PMC4527564/
- https://www.mdpi.com/1422-0067/25/22/12221
- Body Roundness Index (BRI) : https://www.barbellmedicine.com/blog/should-bri-replace-bmi/
Our Sponsors:
* Check out FIGS and use my code FIGSRX for a great deal: https://wearfigs.com
* Check out Factor: https://factormeals.com/bbm50off
* Check out Quince: https://quince.com/BBM
* Check out Quince: https://quince.com/BBM
Support this podcast at — https://redcircle.com/barbell-medicine-podcast/donations
Advertising Inquiries: https://redcircle.com/brands
Privacy & Opt-Out: https://redcircle.com/privacy
View more
